| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8453246 | Journal of Cellular Immunotherapy | 2016 | 10 Pages |
Abstract
These results suggest that the actual selection of HIV+Â individual for immunotherapy, based on clinical features, did not ensure the same DC product, and that less “activated/exhausted” DC could positively affect the outcome of immunotherapy.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alessandra Pontillo, Edione C. Reis, Lais T. da Silva, Alberto J.S. Duarte, Sergio Crovella, Telma M. Oshiro,